'Dna vaccines' diaporamas de présentation

VACCINES

1.79k views • 89 slides

Priyo Wahyudi

1.06k views • 75 slides

Genetic Vaccines

Genetic Vaccines. Dr. Ziad Jaradat. INTRODUCTION.

604 views • 49 slides

Vaccines

H.Sidra Yasin (BIOT 412). Vaccines. What are the Methods to produce the vaccines How we can modify the Vaccines What are the Routs of administration of vaccines What are the Types of vaccines What is Reverse vaccinology and its purpose Summary of all topics with conclusion.

1.35k views • 44 slides

Viruses Treatment and prevention

Viruses Treatment and prevention. Anti-Viral Chemotherapy. Bacteria Many antibiotics Highly selective Viruses Use host cell metabolism Selectivity difficult Toxicity. Anti-Viral Chemotherapy. Key is selectivity Other problems Toxicity Rapid excretion Rapid metabolism

659 views • 43 slides

Types of Vaccines and Patentability Considerations

United States Patent and Trademark Office. Types of Vaccines and Patentability Considerations. Christina Chan Supervisory Primary Examiner Art Unit 1644 Phone: 571-272-0841 E-mail: christina.chan@uspto.gov. Acquisition Of Passive And Active Immunity. Type Acquired through

560 views • 41 slides

Development of HIV vaccine in Russia

Development of HIV vaccine in Russia. A.P.Kozlov The Biomedical Center, Research Institute of Pure Biochemicals and St.Petersburg University St. Petersburg, Russia. The History of Russian HIV Vaccine Project.

583 views • 37 slides

Vaccination against allergy

493 views • 31 slides

Virus Infection

Virus Infection. Major responses of plants and animals to virus infections The scientific basis for prevention and treatment of virus diseases. Transmission of plant viruses. Mechanical Seeds Vegetative propagation/grafting Vectors

1.09k views • 28 slides

Vaccination against allergy

Vaccination against allergy. Ulla Seppälä, PhD Vaccine Research. What is Allergy ?. sensitization. IgE- antibodies. X. Allergic response(s) Immediate-type Delayed- type. Non-IgE mediated hypersensitivity. CD23. B. IgE. APC. T-cell. HLA. -. class II. IgE. Mast cell. T-cell.

414 views • 26 slides

Vaccine induced immunity

Vaccine induced immunity. E. Jenner. Origins of vaccination. Edward Jenner - milk maids did not develop smallpox 1790s - vaccinated 8yr old boy with cowpox - protected from smallpox challenge. E. Jenner. vaccination - vaccinus (Latin) - relating to cows. How do vaccines work?.

726 views • 26 slides

DNA Technology

DNA Technology. Chapter 13 Lab Biology. Genetically Modified Organisms. Modified genome of an organism Takes DNA from multiple sources and combine them to form a new genome DNA from same species DNA from different species- Transgenic organisms. Crops that. Do NOT need fertilizer

306 views • 23 slides

Global DNA Vaccine Market Research and Forecast, 2018-2023

Global DNA vaccine Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

178 views • 16 slides

Vaccine Technology

Vaccine Technology. Vaccine Technology. Vaccine Technology. Vaccine Technology. Vaccine Technology. Newer Technology for Dosing:. Vaccine Technology. New Target Groups:. >100 million eggs used for influenza in the USA every year. Vaccine Technology. Old Technology:

580 views • 15 slides

Vaccine types from Creative Biolabs

A conjugate vaccine is created by covalently attaching a poor antigen to a strong antigen thereby eliciting a stronger immunological response to the poor antigen. Most commonly, the poor antigen is a polysaccharide that is attached to strong protein antigen. However peptide/protein and protein/protein conjugates have also been developed. B cell response to a capsular polysaccharide is T cell independent, meaning that B cells can produce antibodies without T cell stimulation. By conjugating the polysaccharide to a protein carrier, a T cell response can be induced. Normally, polysaccharides by themselves cannot be loaded onto the MHC complex of antigen presenting cells (APC) because MHC can only bind peptides.

139 views • 11 slides

Global DNA Vaccines Market

A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. . Get Global DNA Vaccines Market (Type, Technology, Application, End User and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020 market research report Published by Allied Market Research. The Report is available at $4515 for Single User.

395 views • 8 slides

Potential Analysis of Human DNA Vaccines Market to Grow $9,337 Mn with a CAGR of 9.5%, Globally, by 2030

the global potential analysis of human DNA vaccines market is expected to account for $3,762 million by 2020 and reach $9,337 million by 2030, growing at a CAGR of 9.5% from 2020 to 2030.

83 views • 8 slides

Veterinary / Animal Vaccines Market by Product - Size, Share, Demand, Growth & Opportunities

The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to witness highest growth in the forecast period. New product launches and strategic collaborations were key strategies adopted by major industry players to increase their market share and cater to unmet needs. Emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to favorable government initiatives. Read more details at: http://www.bigmarketresearch.com/veterinary-animal-vaccines-mnm-market

296 views • 6 slides

Global DNA Vaccines Market Size, Share, Trends, 2014-2020

Get full report & TOC @: http://www.researchbeam.com/dna-vaccines-market DNA vaccines have potential advantages over traditional methods, e.g., low risk of infection, easy transportation and stability at room temperature. The global DNA vaccines market is experiencing rapid growth owing to the factors such as the property of specific antigen targeting, reduced risk of infection compared to conventional vaccines and improved stability. Moreover, relative ease of large-scale manufacturing compared to traditional approach and less storage requirement are some of the key market drivers.

254 views • 5 slides

DNA Vaccines Market by Method, Application and Segment to 2014-2025

The key driving factors responsible for the growth of DNA Vaccines Market include growing vulnerability of population to infectious disease and rising number of antibiotics resistant pathogens have generated the need for effective and low cost vaccination which would provide lasting immunity.

44 views • 3 slides